New drug HS-10518 put to the test in healthy women – no cure yet
NCT ID NCT07264192
First seen Jan 05, 2026 · Last updated May 06, 2026 · Updated 19 times
Summary
This early-stage study tested the safety of a new drug called HS-10518 in 60 healthy women aged 18-40 in China. The goal was to see if the drug is safe and how the body processes it, not to treat infertility. Participants were healthy volunteers, not patients seeking a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY FEMALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
West China Second University Hospital
Chengdu, China
Conditions
Explore the condition pages connected to this study.